>

Auris Stock Profile

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 40px;;'>EAR</div>

Performance

0 / 100

Odds of Distress

80
Analyze Filter   Check how we calculate scores
Equity ratings for Auris Medical Holding Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 28, 2019 and ending today February 26, 2020. Click here to learn more.

Auris Medical Profile

Auris Medical Holding Ltd., a development-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear and vestibular disorders. Auris Medical Holding Ltd. was founded in 1998 and is based in Hamilton, Bermuda. Auris Medical operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 9 people. more on Auris Medical
Auris Medical Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Auris Medical Holding SEC Filings
Auris Medical SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAuris Medical Holding Ltd
ChairmanJames HealyView All
Thematic Classification
Currently Active Investing Idea
  Pharmaceutical Products
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Auris Medical Holding
Piotroski F Score
Academic score to determine the current strength of Auris Medical Holding financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Auris Medical Holding ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Auris Medical representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Auris Medical Holding Ltd (EARS) is traded on BATS Exchange in USA. It is located in Clarendon House and employs 9 people. Auris Medical is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with current market capitalization of 9.64 M. Auris Medical Holding conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 3.27 M outstanding shares of which 34.45 K shares are currently shorted by private and institutional investors with about 0.2 trading days to cover. Auris Medical Holding AG currently holds about 5.31 M in cash with (17.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check Auris Medical Probability Of Bankruptcy

Ownership Allocation (%)

Auris Stock Price Odds Analysis

Odds Below 1.22HorizonTargetOdds Above 1.22
0.06%30 days 1.22 99.94%
Based on normal probability distribution, the odds of Auris Medical to move above current price in 30 days from now is close to 99 (This Auris Medical Holding Ltd probability density function shows the probability of Auris Medical Stock to fall within a particular range of prices over 30 days) .

Auris Stock Top Holders

Auris Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Sabby Management LlcCommon Shares171.9 K278 K
Renaissance Technologies LlcCommon Shares45.7 K74 K
View Auris Medical Diagnostics

Auris Medical Holding Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Auris Stock Against Markets

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Auris Medical Corporate Filings

Auris Medical SEC Reporting

Unclassified Corporate Event

Auris Medical Corporate Directors

Calvin Roberts Non-Executive Independent Director
Mats Blom Director
Antoine Papiernik Non-Executive Independent Director
Continue to Investing Opportunities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Company logos by clearbit